↓ Skip to main content

A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel

Overview of attention for article published in Frontiers in Pharmacology, January 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel
Published in
Frontiers in Pharmacology, January 2024
DOI 10.3389/fphar.2023.1251061
Pubmed ID
Authors

Cesar A. Amaya-Rodriguez, Karina Carvajal-Zamorano, Daniel Bustos, Melissa Alegría-Arcos, Karen Castillo

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 30%
Student > Bachelor 2 20%
Professor 1 10%
Student > Ph. D. Student 1 10%
Unknown 3 30%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 20%
Computer Science 1 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Neuroscience 1 10%
Chemistry 1 10%
Other 0 0%
Unknown 4 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2024.
All research outputs
#14,855,357
of 25,480,126 outputs
Outputs from Frontiers in Pharmacology
#4,666
of 19,841 outputs
Outputs of similar age
#119,540
of 323,634 outputs
Outputs of similar age from Frontiers in Pharmacology
#45
of 687 outputs
Altmetric has tracked 25,480,126 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,841 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,634 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 687 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.